DUBLIN--(BUSINESS WIRE)--The "Global Helicobacter Pylori Diagnostics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The helicobacter pylori diagnostics market is poised to grow by $ 209.59 million during 2020-2024 progressing at a CAGR of 8% during the forecast period.
The reports on helicobacter pylori diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing cost-effectiveness of diagnosis in conjunction with personalized antibiotic therapy and resistance of H. pylori to antibiotics. In addition, growing cost-effectiveness of diagnosis in conjunction with personalized antibiotic therapy is anticipated to boost the growth of the market as well.
The helicobacter pylori diagnostics market analysis includes technology segment and geographic landscapes. This study identifies the rising prevalence of disease as one of the prime reasons driving the helicobacter pylori diagnostics market growth during the next few years.
Companies Mentioned
- Abbott Laboratories
- Becton
- Dickinson and Co.
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- Cardinal Health Inc.
- F. Hoffmann-La Roche Ltd.
- Omega Diagnostics Group Plc
- QIAGEN N.V.
- Quest Diagnostics Inc.
- Thermo Fisher Scientific Inc.
The helicobacter pylori diagnostics market covers the following areas:
- Helicobacter pylori diagnostics market sizing
- Helicobacter pylori diagnostics market forecast
- Helicobacter pylori diagnostics market industry analysis
Key Topics Covered:
1. Executive Summary
- Market Overview
2. Market Landscape
- Market ecosystem
- Value chain analysis
3. Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
4. Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
5. Market Segmentation by Technology
- Market segments
- Comparison by Technology
- Immunoassays - Market size and forecast 2019-2024
- Molecular diagnostics - Market size and forecast 2019-2024
- POC - Market size and forecast 2019-2024
- Market opportunity by Technology
6. Customer landscape
7. Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- APAC - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume driver - Demand led growth
- Volume driver - External factors
- Market challenges
- Market trends
8. Vendor Landscape
- Vendor landscape
- Landscape disruption
9. Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- Cardinal Health Inc.
- F. Hoffmann-La Roche Ltd.
- Omega Diagnostics Group Plc
- QIAGEN N.V.
- Quest Diagnostics Inc.
- Thermo Fisher Scientific Inc.
10. Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
For more information about this report visit https://www.researchandmarkets.com/r/oeuhf6
